Diskin Shiri, Kumar Janardan, Cao Zhiyi, Schuman Joel S, Gilmartin Tim, Head Steven R, Panjwani Noorjahan
New England Eye Center, Department of Ophthalmology, Tufts University School of Medicine, Boston, Massachusetts 02111, USA.
Invest Ophthalmol Vis Sci. 2006 Apr;47(4):1491-9. doi: 10.1167/iovs.05-0736.
To identify differentially expressed glycogenes in trabecular meshwork (TM) of eyes with primary open-angle glaucoma (POAG).
Total RNA was isolated from TM of cadaveric eyes derived from donors with diagnosed glaucomas of different etiologies and from normal control subjects. RNA was amplified and hybridized to the GLYCOv2 oligonucleotide microarray that contains probes for carbohydrate-binding proteins, glycosyltransferases, and other genes involved in the regulation of glycosylation. Statistical analysis was used to identify differentially expressed genes between normal and POAG samples.
This study revealed that POAG TM and normal TM have distinct gene expression profiles. Of the 2001 genes on the array, 19 genes showed differential expression of greater than 1.4-fold in POAG. Mimecan and activinA, which have been shown to be upregulated in models of glaucoma, were both found to be elevated in POAG TM. Many genes were identified for the first time to be differentially regulated in POAG. Among the upregulated genes were: (1) cell adhesion molecules including platelet endothelial cell adhesion molecule-1 and P-selectin, both of which are targets of NFkappaB, which has been shown to be activated in glaucomatous TM; (2) lumican, a core protein of keratan sulfate proteoglycans; and (3) the receptor for IL6, a cytokine that has been shown to be upregulated in TM in response to elevated intraocular pressure. Among the downregulated genes were chondroitin-4-O-sulfotransferase involved in the synthesis of chondroitin sulfate chains and the receptor for PDGFbeta, a growth factor that has been shown to stimulate both TM cell proliferation and phagocytic activity. Results for several genes were confirmed by RTq-PCR.
Microarray technology was used to show, for the first time, that POAG TM has a distinct glycogene expression profile. Differentially expressed glycogenes identified in this study have not been previously investigated for their role in the pathogenesis of POAG and thus are novel factors for further study of the mechanism of the disease and for their possible use as diagnostic markers.
鉴定原发性开角型青光眼(POAG)患者小梁网(TM)中差异表达的糖基因。
从不同病因的已确诊青光眼供体的尸体眼TM以及正常对照受试者的TM中分离总RNA。RNA经扩增后与GLYCOv2寡核苷酸微阵列杂交,该微阵列包含碳水化合物结合蛋白、糖基转移酶及其他参与糖基化调控的基因的探针。采用统计学分析来鉴定正常样本与POAG样本之间差异表达的基因。
本研究显示POAG的TM和正常TM具有不同的基因表达谱。在该阵列上的2001个基因中,有19个基因在POAG中显示出大于1.4倍的差异表达。已证实在青光眼模型中上调的 mimecan 和激活素A在POAG的TM中均升高。许多基因首次被鉴定在POAG中受到差异调节。上调的基因包括:(1)细胞黏附分子,包括血小板内皮细胞黏附分子-1和P-选择素,二者均为NFκB的靶点,已证实在青光眼性TM中被激活;(2)亮氨酸聚糖,硫酸角质素蛋白聚糖的核心蛋白;(3)IL6受体,一种细胞因子,已证实在TM中因眼压升高而上调。下调的基因包括参与硫酸软骨素链合成的软骨素-4-O-磺基转移酶和PDGFβ受体,一种已证可刺激TM细胞增殖和吞噬活性的生长因子。几个基因的结果通过RTq-PCR得到证实。
微阵列技术首次用于显示POAG的TM具有独特的糖基因表达谱。本研究中鉴定出的差异表达糖基因此前尚未研究其在POAG发病机制中的作用,因此是进一步研究该疾病机制及其作为诊断标志物潜在用途的新因素。